Grant Riverside Cancer Services
Columbus, Ohio 43215
0 studies enrolling now · 23 studies all time
What they study most
Anal Cancer, Anemia, Bladder Cancer, Breast Cancer, Fatigue, Head and Neck Cancer, Hot Flashes, Kidney Cancer, Leukemia, Lung Cancer, Lymphoma, Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
Studies at this site
- Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma — Completed
- Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer — Completed
- Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer — Completed
- Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer — Completed
- Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy — Completed
- S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer — Completed
- S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED) — Stopped early
- Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer — Completed
- Citalopram in Treating Postmenopausal Women With Hot Flashes — Completed
- S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma — Completed
- Combination Chemotherapy in Treating Patients With Bladder Cancer — Completed
- Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) — Completed
- Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer — Completed
- Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer — Completed
- Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer — Completed
- S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer — Completed
- S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia — Completed
- S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia — Completed
- Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer — Stopped early
- S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma — Completed
- S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery — Completed
- S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer — Withdrawn before enrolling
- SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma — Completed